|
- 2019
Pharmacokinetics, pharmacodynamics, safety, and immunogenicity of Pelmeg?, a pegfilgrastim biosimilar in healthy subjectsDOI: 10.1002/prp2.503 Keywords: biosimilar, filgrastim, myelosuppressive chemotherapy, Neulasta, neutropenia, oncology, pegfilgrastim, Pelmeg, supportive care Abstract:
|